First-in-man phase I trial of two schedules of the novel synthetic tetrahydroisoquinoline alkaloid PM00104 (Zalypsis) in patients with advanced solid tumours.
Br J Cancer
; 106(8): 1379-85, 2012 Apr 10.
Article
em En
| MEDLINE
| ID: mdl-22491421
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Tetra-Hidroisoquinolinas
/
Neoplasias
/
Antineoplásicos
Limite:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Ano de publicação:
2012
Tipo de documento:
Article